Maintain HOLD with tiered add triggers and downside contingency to convert passive flat-weight into active architecture
This is a "great franchise, suboptimal trade" situation — JPM's structural quality (17.8% ROE, $25.51B NII, $20B QIA mandate, $1.65 dividend, $8.8B quarterly buyback) warrants continued ownership, but the current $340 entry offers insufficient margin of safety for fresh capital beyond disciplined tiered triggers. The HOLD must include active architecture (upside adds + downside contingency) because passive Hold has bled alpha twice in 8 days (9/18: -0.9%, 9/21: -3.4%), and pre-committed Underweight historically overshoots against the franchise floor. Key risks: 10Y above 5.25%, AI-disruption narrative escalation, QIA mandate deployment pace. Key catalyst: Q3 earnings mid-October resolving NII trajectory, credit cost normalization, and Dimon succession commentary.
| Position | Action |
|---|---|
| Current weight 3-4% at $340 | No immediate action |
| Price reaches $319-325 zone with stabilization signals (volume contraction, daily range compression, RSI basing above 30) | Add 1-1.5% allocation |
| Price reclaims $349.92 on closing basis with rising volume and MACD histogram contraction | Add 0.5-1% allocation |
| Maximum exposure cap | Do not exceed 5% total |
| Price stalls below $319 for 5-7 sessions without stabilization OR closes below $319 on above-average volume | Trim 15-20% of position (lower bound per 9/15/9/16 reflections; NOT 30-35%) |
JPM's current sell-off represents a historically attractive risk/reward entry point, as the stock's strong fundamental performance—including record NII, 17.79% ROE, and 41% earnings growth—far outweighs short-term technical weakness, and the valuation at 13.61x forward P/E with a 3.4pp earnings yield premium over Treasuries does not reflect the earnings power of this $5T franchise.
| Indicator | Value | Signal |
|---|---|---|
| Close | $340.00 | neutral |
| 10 EMA | $349.92 | bearish |
| 50 SMA | $353.62 | bearish |
| 200 SMA | $319.11 | neutral |
| RSI | 35.40 | bearish |
| MACD | −1.78 | bearish |
| MACD Signal | −0.27 | bearish |
| MACD Histogram | −1.51 | bearish |
| Bollinger Middle (20 SMA) | $353.67 | bearish |
| Bollinger Upper | $362.97 | bearish |
| Bollinger Lower | $344.38 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
· concedes: Momentum is currently negative; MACD is negative and histogram is expanding; RSI at 35.4, not yet oversold; Stock closed at $340 on Sept 22, breaking below $349–$352 consolidation floor; The AI narrative might compress multiples by 50–100 basis points
JPM is a cyclical megabank at peak-cycle earnings using peak leverage, trading at 14.6x P/E near the top of its historical band with a hawkish Fed and late credit cycle backdrop that will compress NII and trigger credit losses; the technical breakdown is confirmed and the risk/reward is decisively asymmetric to the downside.
· concedes: The bull is right that momentum is currently negative; JPM is the highest-quality franchise in U.S. banking and will likely be a multi-year compounder; The earnings power is real; Q2 was a genuinely impressive quarter with strong fundamental results
→ vs conservative: Band walk below lower Bollinger Band on fundamentally excellent name is capitulation event, not start of new leg down; dividend hike from $1.50 to $1.65 and $20B QIA mandate announced same day as 3% selloff proves macro tape damage, not fundamental deterioration
→ vs conservative: Net debt tripling from $65B to $223B funds productive asset growth at 10.2% expansion; 5 consecutive quarters operating revenue compounding with no down quarters proves leverage deployed at high returns, not balance sheet deterioration
→ vs conservative: AI threat is multiple compression story, not earnings collapse story; market already pricing substantial compression at 14.6x P/E for 40%+ growth
→ vs conservative: Waiting for confirmation forfeits dividend yield, annualized $35B buyback, and compounding per-share economics; time in market beats timing market for 17.8% ROE franchise
→ vs neutral: Entry at $349.92 and stop at $319 creates wrong framework; buying after $10 confirmation compresses risk/reward, waiting for $319 flush may never come as 200 SMA has historically been fortress level
→ vs neutral: 10-year yield above 5% is being overweighted as risk; JPM's NII has expanded 5 consecutive quarters despite yield volatility, management navigating curve at 17.8% ROE while peers earn 10-12%
→ vs neutral: The September 22 selloff happened ON the same day JPM announced $20B QIA mandate and 10% dividend hike; that's forced selling creating entry point, not exit signal
| bearish |
| ATR | $7.21 | neutral |
| VWMA | $351.28 | bearish |
| Volume | 11,403,647 | bearish |
| Intraday Range | $14.80 | bearish |
Support: 319.11 · 330 · 333 · 337.72 · 344.38 | Resistance: 349.92 · 351.55 · 352 · 353.23 · 353.62 · 353.67 · 365.18
JPMorgan Chase (JPM) is in a firm bearish downtrend, having broken decisively below the $349–$352 consolidation floor with a high-volume bearish candle on September 22, closing at $340.00 (lowest since mid-July). All short- and medium-term technical indicators are bearish: the 10 EMA ($349.92), 50 SMA ($353.62), and Bollinger Lower Band ($344.38) are all broken, MACD is expanding negatively at −1.78, and RSI at 35.40 suggests further downside room before oversold territory. The 200 SMA at $319.11 (~6.1% below) is the last structural support, with the July swing low zone of $330–$333 as intermediate support. ATR has doubled to $7.21, requiring wider stop widths; no reversal signals are present until price reclaims $349.92 on a closing basis.
Market Cap
$903.78B
P/E (TTM)
14.57x
Forward P/E
13.61x
PEG Ratio
1.64
P/B
2.56x
EPS (TTM)
$23.34
Forward EPS
$24.99
Dividend Yield
1.87%
Beta
0.975
52-Week High
$366.50
52-Week Low
$279.10
50-Day Moving Avg
$353.51
200-Day Moving Avg
$320.76
TTM Revenue
$186.33B
TTM Net Income
$63.63B
TTM Profit Margin
34.92%
Operating Margin
50.39%
ROE
17.79%
ROA
1.36%
Q2 2026 Revenue
$52.85B
Q2 2026 Net Income
$21.16B
Q2 2026 Diluted EPS
$7.70
Q2 2026 YoY EPS Growth
~+47%
Q2 2026 Net Interest Income
$25.51B
Q2 2026 Pretax Income
$27.52B
Q2 2026 Tax Provision
$6.36B
Q2 2026 Effective Tax Rate
23.1%
Q2 2025 Revenue
$44.88B
Q2 2025 Net Income
$14.99B
Q2 2025 Diluted EPS
$5.24
Q2 2025 Net Interest Income
$23.21B
Total Assets
$5,015.1B
Net Loans
$1,516.3B
Total Equity
$374.6B
Tangible Book Value
$289.3B
Total Debt
$533.0B
Net Debt
$223.1B
Common Stock Equity
$353.6B
Investments & Advances
$1,586.7B
Trading Securities
$794.2B
Cash & Equivalents
$309.8B
Goodwill & Intangibles
$64.3B
Q2 2026 YoY Asset Growth
+10.2%
Q2 2026 YoY Loan Growth
+9.3%
Q2 2026 Operating Cash Flow
-$25.3B
Q2 2026 Buybacks
$8.8B
Q2 2026 Dividends Paid
$4.3B
Q2 2026 LT Debt Issuance
$35.6B
Treasury Stock Balance
$178.4B
Strengths
Concerns
JPMorgan Chase reported outstanding Q2 2026 results with revenue of $52.85B and net income of $21.16B, up 18% and 41% YoY respectively, powered by five consecutive quarters of NII expansion. The bank maintains fortress-level fundamentals with 17.79% ROE, 34.92% profit margin, and a P/E of 14.57x that remains undemanding relative to its growth profile, while aggressively returning capital via $8.8B in quarterly buybacks and $4.3B in dividends. Despite near-term valuation concerns at 52-week highs and credit cycle risks to monitor, the bank offers a favorable 12-month risk/reward for patient investors with an expected ~7% forward EPS growth to $24.99.
Macro: Fed delivered a 25bp rate hike (first since 2023) with 86% probability of another hike in 2026 and 62% probability of two hikes total; recession odds collapsed 13pp to 8% in one week; 10Y Treasury above 5% (redline breached); Brent crude ~$100 and gasoline ~$5 amid Iran war; Polymarket US recession by EOY 2026 priced at 8%; higher-for-longer rate regime consensus.